RECENT PLACEMENT

Occam Places Bastiano Sanna as CEO of Semma

Occam Places Bastiano Sanna as CEO of Semma

Semma Therapeutics is a cell therapy company founded by Doug Melton of Harvard University and financed by ARCH Venture, MPM, and F-Prime. The company was subsequently acquired by Vertex for approximately $1B in late 2019.

Bastiano Sanna was a first-time CEO, who brought a Ph.D. in pharmacology, experience in investment banking (Leerink), exposure to strategy & portfolio management (NIBR), and entrepreneurial operating chops as the “Number Two” at Magenta, a cell therapy company that subsequently went public.

‍

Related Placements

  1. Suzanne “Sue” Bruhn CEO of Prominent Rare Disease Research Foundation
  2. Vatnak Vat-Ho as CBO at Ryvu Therapeutics
  3. Steve Colletti as CSO of Korro Bio
  4. Theo Karaletsos as VP, Data Science/ML at insitro
  5. Sana Hafeez as Head of People at Unlearn
About Occam Global

Occam Global is a trusted executive search, consulting, and investment partner for leaders and investors shaping the future of life sciences, deep tech, and venture capital. Since 2012, we’ve helped build high-performing teams and advised visionary companies from stealth to public markets. Our success stems from exceptional access to rare talent, deep sector expertise, and a commitment to results guided by elevated ethics and enlightened aggression.